REPL

NASDAQ · Equity

Replimune Group Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
8.690000
Fair value
10.249359
Expectation
Undecided 50.77%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
8.69
12-Week Change
21.71%
Trend Signal
Inactive
Expectation
Undecided 50.77%
Signal Weeks
1 of 12
Vs Trend Line
Above
Vs Fair Value
Below
Relative Strength
-3.06
Market Dynamics
-0.20

Over the latest 12 completed weeks ending 2026-05-29, REPL rose 21.71%, moving from 7.14 to 8.69. The latest weekly close is above the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 1 of the last 12 weeks. Relative Strength is -3.06 and has improved across the 12-week window. Market Dynamics is -0.20 on the latest week. Expectation is undecided at 50.77%.